Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- A1664 CelecoxibTarget: COXSummary: Selective cyclooxygenase-2 (COX-2) inhibitor
- A2890 NepafenacSummary: COX-1 and COX-2 inhibitor
- A5791 Ibuprofen LysineSummary: COX inhibitor
- A8446 IbuprofenTarget: COXSummary: inhibitor of cyclooxygenase 1 and cyclooxygenase 2
- A8449 IndomethacinTarget: COXSummary: Cox inhibitor
- A8466 Meloxicam (Mobic)Target: COXSummary: Nonsteroidal anti-inflammatory drug
- A8503 PiroxicamTarget: COX|Prostaglandin synthesisSummary: Prostaglandin synthesis/Coxinhibitor
- B5347 SC 58125Summary: COX-2 inhibitor
- B4796 Meclofenamate SodiumSummary: dual COX-1/COX-2 inhibitor
- B4807 FirocoxibSummary: COX2 inhibitor